Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

How I treat dysfibrinogenemia

Alessandro Casini, Philippe de Moerloose

Blood (2021) 138 (21): 2021–2030.

https://doi.org/10.1182/blood.2020010116

Published: 2021

Journal Articles

Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia

Alessandro Casini, Sylvia von Mackensen, Cristina Santoro, Claudia Djambas Khayat, Meriem Belhani, Cecil Ross, Akbar Dorgalaleh, Arshi Naz, Ekrem Ünal, Magy Abdelwahab, Elise Dupuis Lozeron, Nathalie Trillot, Sophie Susen, Flora Peyvandi, Philippe de Moerloose

Blood (2021) 137 (22): 3127–3136.

https://doi.org/10.1182/blood.2020009472

Published: 2021

Includes: Supplemental data

Journal Articles

Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)

Blood (2016) 128 (22): 207.

https://doi.org/10.1182/blood.V128.22.207.207

Published: 2016

Journal Articles

Renal Status and Hematuria in Older Patients with Hemophilia

Pal André Holme, PhDMD, Robert Campbell Tait, MD, Christophe Combescure, PhD, Erik Berntorp, MD PhD, Annarita Tagliaferri, Peter Staritz, MD, Roger E.G. Schutgens, MD PhD, Robert Klamroth, Natascha Marquardt, Stephan Rauchensteiner, Philippe De Moerloose, MD PhD

Blood (2015) 126 (23): 2290.

https://doi.org/10.1182/blood.V126.23.2290.2290

Published: 2015

Journal Articles

Natural history of patients with congenital dysfibrinogenemia

Alessandro Casini, Marc Blondon, Aurélien Lebreton, Jérémie Koegel, Véronique Tintillier, Emmanuel de Maistre, Philippe Gautier, Christine Biron, Marguerite Neerman-Arbez, Philippe de Moerloose

Blood (2015) 125 (3): 553–561.

https://doi.org/10.1182/blood-2014-06-582866

Published: 2015

Includes: Supplemental data

Journal Articles

Prospective Data Collection on Patients with Fibrinogen and Factor XIII Deficiencies: Prelimary Results of the PRO-RBDD Project

Blood (2014) 124 (21): 2838.

https://doi.org/10.1182/blood.V124.21.2838.2838

Published: 2014

Journal Articles

Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies

Nathalie Satta, Egbert K. O. Kruithof, Céline Fickentscher, Sylvie Dunoyer-Geindre, Françoise Boehlen, Guido Reber, Danielle Burger, Philippe de Moerloose

Blood (2011) 117 (20): 5523–5531.

https://doi.org/10.1182/blood-2010-11-316158

Published: 2011

Includes: Supplemental data

Journal Articles

Anticoagulants in portal vein thrombosis: don't be so shy!

Laurent Spahr, Françoise Boehlen, Philippe de Moerloose, Antoine Hadengue

Blood (2009) 113 (20): 5031–5032.

https://doi.org/10.1182/blood-2009-02-202770

Published: 2009

Journal Articles

Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency

Beat Nyfeler, Yukiko Kamiya, Françoise Boehlen, Kazuo Yamamoto, Koichi Kato, Philippe de Moerloose, Hans-Peter Hauri, Marguerite Neerman-Arbez

Blood (2008) 111 (3): 1299–1301.

https://doi.org/10.1182/blood-2007-09-112854

Published: 2008

Journal Articles

The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies

Nathalie Satta, Sylvie Dunoyer-Geindre, Guido Reber, Richard J. Fish, Francoise Boehlen, Egbert K. O. Kruithof, Philippe de Moerloose

Blood (2006) 109 (4): 1507–1514.

https://doi.org/10.1182/blood-2005-03-024463

Published: 2006

Includes: Supplemental data

Journal Articles

Genetic and Phenotypic Analysis of Families with Inherited Hypo- and Dys-Fibrinogenemia. Fibrinogen Bratislava.

Angelika Batorova, MD, PhD, Daniela Horvathova, MD, Martin Mistrik, MD, PhD, Philippe de Moerloose, MD, PhD, Marguerite Neerman-Arbez, MD, PhD

Blood (2005) 106 (11): 1794.

https://doi.org/10.1182/blood.V106.11.1794.1794

Published: 2005

Journal Articles

Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells

Marguerite Neerman-Arbez, Myrna Germanos-Haddad, Konstantinos Tzanidakis, Dung Vu, Samuel Deutsch, Armelle David, Michael A. Morris, Philippe de Moerloose

Blood (2004) 104 (12): 3618–3623.

https://doi.org/10.1182/blood-2004-06-2312

Published: 2004

Journal Articles

Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion

Dung Vu, Paula H. B. Bolton-Maggs, Jeremy R. Parr, Michael A. Morris, Philippe de Moerloose, Marguerite Neerman-Arbez

Blood (2003) 102 (13): 4413–4415.

https://doi.org/10.1182/blood-2003-06-2141

Published: 2003

Journal Articles

End-stage liver disease in persons with hemophilia and transfusion-associated infections

Blood (2002) 100 (5): 1584–1589.

https://doi.org/10.1182/blood.V100.5.1584.h81702001584_1584_1589

Published: 2002

Journal Articles

Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G→T

Catia Attanasio, Philippe de Moerloose, Stylianos E. Antonarakis, Michael A. Morris, Marguerite Neerman-Arbez

Blood (2001) 97 (6): 1879–1881.

https://doi.org/10.1182/blood.V97.6.1879

Published: 2001

Journal Articles

Mutations in the fibrinogen Aα gene account for the majority of cases of congenital afibrinogenemia

Marguerite Neerman-Arbez, Philippe de Moerloose, Claire Bridel, Ariane Honsberger, Anni Schönbörner, Colette Rossier, Kathelijne Peerlinck, Ségolène Claeyssens, Donna Di Michele, Roseline d'Oiron, Marie Dreyfus, Monique Laubriat-Bianchin, Jacelyne Dieval, Stylianos E. Antonarakis, Michael A. Morris

Blood (2000) 96 (1): 149–152.

https://doi.org/10.1182/blood.V96.1.149

Published: 2000

NARROW

How I treat dysfibrinogenemia

Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia

Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)

Renal Status and Hematuria in Older Patients with Hemophilia

Natural history of patients with congenital dysfibrinogenemia

Prospective Data Collection on Patients with Fibrinogen and Factor XIII Deficiencies: Prelimary Results of the PRO-RBDD Project

Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies

Anticoagulants in portal vein thrombosis: don't be so shy!

Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency

The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies

Genetic and Phenotypic Analysis of Families with Inherited Hypo- and Dys-Fibrinogenemia. Fibrinogen Bratislava.

Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells

Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion

End-stage liver disease in persons with hemophilia and transfusion-associated infections

Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G→T

Mutations in the fibrinogen Aα gene account for the majority of cases of congenital afibrinogenemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only